Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Income towards Parent Company (2024 - 2025)

Historic Income towards Parent Company for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.2 million.

  • Connect Biopharma Holdings' Income towards Parent Company fell 3358.19% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.3 million, marking a year-over-year decrease of 63307.05%. This contributed to the annual value of -$15.6 million for FY2024, which is 12626.42% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Income towards Parent Company of -$17.2 million as of Q3 2025, which was down 3358.19% from -$12.9 million recorded in Q2 2025.
  • Connect Biopharma Holdings' Income towards Parent Company's 5-year high stood at $14.8 million during Q2 2024, with a 5-year trough of -$17.2 million in Q3 2025.